Nerve Repair and Regeneration Market by Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Neurostimulation Devices) by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery) - Global Forecast to 2022
Nerves are specialized cells which help carry messages from one part of the body to another, as tiny electrical signals. Pressure or stretching injuries can cause fibers within the nerve to break. Injury to a nerve can stop signals to and from the brain. Nerve repair and regeneration products are used by medical professionals to restore normal function to damaged nerves. Nerve damage can be caused either due to blunt trauma (such as an impact from a fall or from traction injuries from motor vehicle accidents) or sharp trauma (such as from a direct cut from a knife). Surgical nerve repair involves the exploration of the injured nerve and removal of injured tissue from the nerve endings. In these surgeries, nerve repair and regeneration products are used to restore the normal functioning of nerves. The global nerve repair and regeneration market is expected to reach USD 10.5 Billion by 2022 from USD 5.7 Billion in 2017, at a CAGR of 12.9% during forecast period. The major factors driving the growth of this market are the high incidence of nerve injuries, growing prevalence of neurological disorders, growing geriatric population, and availability of technologically advanced nerve repair and regeneration products. On the other hand, the dearth of trained professionals and a stringent regulatory framework are expected to hinder the growth of this market to a certain extent. Considering the potential applications of stem cell therapy in the treatment of several neurological conditions, coupled with its advantages over nerve graft surgeries, stem cell therapy for nerve repair and regeneration can be a potential growth area for market players in the coming years.
By product, neurostimulation and neuromodulation devices segment is expected to grow at the highest growth rate during the forecast period
The neurostimulation and neuromodulation devices segment is projected to register the highest during the forecast period. Increasing incidence of peripheral nerve injuries, technological advancement in the field, and favorable reimbursement policies are expected to drive the growth of this market segment in the next five years.
By application type, neurostimulation and neuromodulation surgeries segment to record the highest CAGR during the forecast period
Neurostimulation and neuromodulation surgeries application segment is projected to register a higher CAGR during the forecast period. The higher CAGR of this segment can primarily be attributed to the increasing incidence of peripheral nerve injuries and neurological disorders across the globe.
By end user type, hospitals & clinics segment to record the highest CAGR during the forecast period
Hospitals & clinics end user segment is projected to register a higher CAGR during the forecast period. The growth of this segment is mainly attributed to factors such as increased patient pool, growth in the number of nerve repair and neurological procedures in hospitals, rapid growth in the geriatric population, improving healthcare infrastructure, and favorable reimbursement scenario in most countries.
North America to account for the largest market size during the forecast period.
North America is expected to account for the largest share of this market. The large share of this regional segment can primarily be attributed to the rising incidence of neurological disorders, favorable reimbursement policies, and the strong presence of industry players in this region.
Market Dynamics
Driver: High Incidence of Nerve Injuries
It is estimated that about 250,000 peripheral nerve injuries occur annually in the US alone, which accounts for around 42% of the global peripheral nerve injuries. According to a recent study, around 87% of peripheral nerve injuries are caused due to trauma, while the rest are caused due to tumor- and non-tumor-related surgeries. Surgical manipulation or transection during tissue removal can also cause nerve damage. As the number of such injuries is high, the demand for biomaterials such as nerve conduits, nerve wraps, nerve protectors, and nerve connectors is increasing across the globe. This is a major factor aiding the growth of the nerve repair and regeneration market.
Opportunity: Potential of Stem Cell Therapy in Nerve Repair and Regeneration
Stem cell therapy, an emerging branch of medicine that has the potential to restore organ and/or tissue function in patients suffering from serious injuries or chronic diseases, is showing significant potential in nerve repair applications. Based on clinical research findings, stem cell therapy offers better quality results than nerve graft surgeries. Furthermore, stem cell therapy is currently being studied for the treatment of Parkinsons disease and Alzheimers disease. Considering the potential applications of stem cell therapy in the treatment of several neurological conditions, coupled with its advantages over nerve graft surgeries, stem cell therapy for nerve repair and regeneration can be a potential growth area for market players in the coming years.
Restraints: Greater Preference of Drug Therapies over Nerve Repair and Regeneration Products
For the treatment of neurological disorders, the preference for drug therapies is higher among patients. This is because there is limited awareness among patients about the availability of alternative surgical treatments that make use of nerve repair and regeneration devices. Moreover, surgeons in several countries have limited knowledge about the various biomaterials (allografts, autografts, and xenografts) and neuromodulation (sacral nerve stimulation and vagus nerve stimulation) devices used in nerve repair and regeneration. For instance, the overactive bladder (OAB) syndrome remains untreated in many individuals across the globe due to the lack of awareness about effective treatment options, such as sacral nerve stimulation. Thus, the lack of awareness about the benefits of using biomaterials or neuromodulation devices in the treatment of several neurological disorders is expected to restrain the growth of this market during the forecast period.
Scope of the Report
|
Report Metric |
Details |
|
Market size available for years |
20162022 |
|
Base year considered |
2016 |
|
Forecast period |
20172022 |
|
Forecast units |
Million (USD) |
|
Segments covered |
By Product, By Application, By End User and By Geography |
|
Geographies covered |
North America, Europe, Asia, Rest of the World |
|
Companies covered |
Axogen, Baxter, Boston Scientific, Livanova, Integra Lifesciences, Medtronic, Abbott Laboratories, Stryker, Polyganics, Nuvectra, Neuropace, Orthomed, Nervo |
The research report categorizes the mycoplasma testing market into the following segments and subsegments:
By Product
- Neurostimulation and Neuromodulation Devices
- Internal Neurostimulation Devices
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Vagus Nerve Stimulation
- Sacral Nerve Stimulation
- Gastric Electrical Stimulation
- External Neurostimulation Devices
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
- Internal Neurostimulation Devices
- Biomaterials
- Nerve Conduits
- Nerve Protectors
- Nerve Wraps
- Nerve Connectors
By Application
- Neurostimulation and Neuromodulation Surgeries
- Internal Neurostimulation and Neuromodulation Surgeries
- External Neurostimulation and Neuromodulation Surgeries
- Direct Nerve Repair/Neurorrhaphy
- Epineural Repair
- Perineural Repair
- Group Fascicular Repair
- Nerve Grafting
- Autografts
- Allografts
- Xenografts
- Stem Cell Therapy
By End User
- Hospitals & Clinics
- Ambulatory Surgery Centers
By Region
- North America
- US
- Canada
- Europe
- Asia
- Japan
- China
- India
- Rest of Asia
- Rest of The World
Key Market Players
Medtronic Plc, Boston Scientific Corporation, Abbott Laboratories Ltd., LivaNova, PLC, Stryker Corporation and Baxter International Inc., AxoGen, Integra LifeSciences, Nevro, Polyganics, Nuvectra, NeuroPace, OrthoD, EnteroMedics, Cirtec Medical, Integer Holdings, Aleva Neurotherapeutics, Biowave, NeuroSigma, BioControl Medical, Synapse Biomedical, Medovent, Collagen Matrix, Checkpoint Surgical, and Cerbomed
Recent Developments
Critical questions the report answers:
- Where will all these developments take the industry in the long term?
- What are the upcoming trends for the nerve repair and regeneration market?
- Which segment provides the most opportunity for growth?
- Who are the leading vendors operating in this market?
- What are the opportunities for new market entrants?
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 12)
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for The Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. - 15)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Executive Summary (Page No. - 22)
4 Premium Insights (Page No. - 25)
4.1 Nerve Repair and Regeneration: Market Overview
4.2 Asian Nerve Repair and Regeneration Market, By Application and Country
4.3 Global Nerve Repair and Regeneration Market: Geographic Snapshot
4.4 Nerve Grafting Market, By Type
5 Market Overview (Page No. - 28)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Incidence Of Nerve Injuries
5.2.1.2 Rising Geriatric Population and Subsequent Growth In Prevalence Of Neurological Disorders
5.2.1.3 Technological Advancements
5.2.2 Restraints
5.2.2.1 Greater Preference for Drug Therapies Over Nerve Repair and Regeneration Products
5.2.2.2 Dearth Of Trained Professionals
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Potential Of Stem Cell Therapy In Nerve Repair and Regeneration
5.2.4 Challenges
5.2.4.1 Donor-Site Morbidity
5.2.4.2 Difficulties In Treating Large Nerve Gaps
5.2.4.3 Stringent Regulatory Frameworks and Time-Consuming Approval Processes
6 Nerve Repair and Regeneration Market, By Product (Page No. - 32)
6.1 Introduction
6.2 Neurostimulation and Neuromodulation Devices
6.2.1 Internal Neurostimulation Devices
6.2.1.1 Spinal Cord Stimulation
6.2.1.2 Deep Brain Stimulation
6.2.1.3 Vagus Nerve Stimulation
6.2.1.4 Sacral Nerve Stimulation
6.2.1.5 Gastric Electrical Stimulation
6.2.2 External Neurostimulation Devices
6.2.2.1 Tens
6.2.2.2 Tms
6.3 Biomaterials
6.3.1 Nerve Conduits
6.3.2 Nerve Protectors
6.3.3 Nerve Wraps
6.3.4 Nerve Connectors
7 Nerve Repair and Regeneration Market, By Application (Page No. - 45)
7.1 Introduction
7.2 Neurostimulation and Neuromodulation Surgeries
7.2.1 Internal Neurostimulation and Neuromodulation Surgeries
7.2.2 External Neurostimulation and Neuromodulation Surgeries
7.3 Direct Nerve Repair/Neurorrhaphy
7.3.1 Epineural Repair
7.3.2 Perineural Repair
7.3.3 Group Fascicular Repair
7.4 Nerve Grafting
7.4.1 Autografts
7.4.2 Allografts
7.4.3 Xenografts
7.5 Stem Cell Therapy
8 Nerve Repair and Regeneration Market, By End User (Page No. - 55)
8.1 Introduction
8.2 Hospitals & Clinics
8.3 Ambulatory Surgery Centers
9 Nerve Repair and Regeneration Market, By Region (Page No. - 59)
9.1 Introduction
9.2 North America
9.2.1 Us
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 Uk
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.5 Rest Of Europe (Roe)
9.4 Asia
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest Of Asia (Roa)
9.5 Rest Of The World (Row)
10 Competitive Landscape (Page No. - 83)
10.1 Introduction
10.2 Market Share Analysis
10.3 Competitive Situation and Trends
10.3.1 Regulatory Approvals
10.3.2 Mergers and Acquisitions
10.3.3 Product Launches
10.3.4 Agreements, Collaboration and Partnerships
11 Company Profiles (Page No. - 87)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, Mnm View)*
11.1 Axogen
11.1.1 Overview
11.1.2 Product Offered
11.1.3 Product Offering Scorecard
11.1.4 Business Strategy Scorecard
11.1.5 Recent Developments (2014 March 2017)
11.2 Baxter
11.2.1 Overview
11.2.2 Product Offered
11.2.3 Product Offering Scorecard
11.2.4 Business Strategy Scorecard
11.2.5 Recent Developments (2014 March 2017)
11.3 Boston Scientific
11.3.1 Overview
11.3.2 Product Offered
11.3.3 Product Offering Scorecard
11.3.4 Business Strategy Scorecard
11.3.5 Recent Developments (2014 March 2017)
11.4 Livanova
11.4.1 Overview
11.4.2 Product Offered
11.4.3 Product Offering Scorecard
11.4.4 Business Strategy Scorecard
11.4.5 Recent Developments (2014 March 2017)
11.5 Integra Lifesciences
11.5.1 Overview
11.5.2 Product Offered
11.5.3 Product Offering Scorecard
11.5.4 Business Strategy Scorecard
11.5.5 Recent Developments (2014 March 2017)
11.6 Medtronic
11.7 Abbott Laboratories
11.8 Stryker
11.9 Polyganics
11.1 Nuvectra
11.11 Neuropace
11.12 Orthomed
11.13 Nevro
*Details On Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured In Case Of Unlisted Companies.
12 Appendix (Page No. - 113)
12.1 Insights Of Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets Subscription Portal
12.4 Introducing Rt: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports
12.7 Author Details
List of Tables (83 Tables)
Table 1 Nerve Repair and Regeneration Market, By Product,20152022 (USD Million)
Table 2 Neurostimulation and Neuromodulation Devices Market,By Type, 20152022 (USD Million)
Table 3 Neurostimulation and Neuromodulation Devices Market,By Region, 20152022 (USD Million)
Table 4 Internal Neurostimulation Devices Market, By Type,20152022 (USD Million)
Table 5 Internal Neurostimulation Devices Market, By Region,20152022 (USD Million)
Table 6 Spinal Cord Stimulation Devices Market, By Region,20152022 (USD Million)
Table 7 Deep Brain Stimulation Devices Market, By Region,20152022 (USD Million)
Table 8 Vagus Nerve Stimulation Devices Market, By Region,20152022 (USD Million)
Table 9 Sacral Nerve Stimulation Devices Market, By Region,20152022 (USD Million)
Table 10 Gastric Electrical Stimulation Devices Market, By Region,20152022 (USD Million)
Table 11 External Neurostimulation Devices Market, By Type,20152022 (USD Million)
Table 12 External Neurostimulation Devices Market, By Region,20152022 (USD Million)
Table 13 Tens Devices Market, By Region, 20152022 (USD Million)
Table 14 Tms Devices Market, By Region, 20152022 (USD Million)
Table 15 Biomaterials Market, By Type, 20152022 (USD Million)
Table 16 Biomaterials Market, By Region, 20152022 (USD Million)
Table 17 Nerve Conduits Market, By Region, 20152022 (USD Million)
Table 18 Nerve Protectors Market, By Region, 20152022 (USD Million)
Table 19 Nerve Wraps Market, By Region, 20152022 (USD Million)
Table 20 Nerve Connectors Market, By Region, 20152022 (USD Million)
Table 21 Nerve Repair and Regeneration Market, By Application,20152022 (USD Million)
Table 22 Neurostimulation and Neuromodulation Surgeries Market,By Type, 20152022 (USD Million)
Table 23 Neurostimulation and Neuromodulation Surgeries Market,By Region, 20152022 (USD Million)
Table 24 Internal Neurostimulation and Neuromodulation Surgeries Market, By Region, 20152022 (USD Million)
Table 25 External Neurostimulation and Neuromodulation Surgeries Market, By Region, 20152022 (USD Million)
Table 26 Direct Nerve Repair/Neurorrhaphy Market, By Type,20152022 (USD Million)
Table 27 Direct Nerve Repair/Neurorrhaphy Market, By Region,20152022 (USD Million)
Table 28 Epineural Repair Market, By Region, 20152022 (USD Million)
Table 29 Perineural Repair Market, By Region, 20152022 (USD Million)
Table 30 Group Fascicular Repair Market, By Region, 20152022 (USD Million)
Table 31 Nerve Grafting Market, By Type, 20152022 (USD Million)
Table 32 Nerve Grafting Market, By Region, 20152022 (USD Million)
Table 33 Autografts Market, By Region, 20152022 (USD Million)
Table 34 Allografts Market, By Region, 20152022 (USD Million)
Table 35 Xenograft Market, By Region, 20152022 (USD Million)
Table 36 Stem Cell Therapy Market, By Region, 20152022 (USD Million)
Table 37 Nerve Repair and Regeneration Market Size, By End User,20152022 (USD Million)
Table 38 Nerve Repair and Regeneration Market for Hospitals & Clinics,By Region, 20152022 (USD Million)
Table 39 Nerve Repair and Regeneration Market for Ambulatory Surgery Centers, By Region, 20152022 (USD Million)
Table 40 Nerve Repair and Regeneration Market, By Region,20152022 (USD Million)
Table 41 North America: Nerve Repair and Regeneration Market,By Country, 20152022 (USD Million)
Table 42 North America: Nerve Repair and Regeneration Market,By Product, 20152022 (USD Million)
Table 43 North America: Neurostimulation and Neuromodulation Devices Market, By Type, 20152022 (USD Million)
Table 44 North America: Internal Neurostimulation Devices Market,By Type, 20152022 (USD Million)
Table 45 North America: External Neurostimulation Devices Market,By Type, 20152022 (USD Million)
Table 46 North America: Biomaterials Market, By Type, 20152022 (USD Million)
Table 47 North America: Nerve Repair and Regeneration Market,By Application, 20152022 (USD Million)
Table 48 North America: Nerve Repair and Regeneration Market,By End User, 20152022 (USD Million)
Table 49 Us: Nerve Repair and Regeneration Market, By End User,20152022 (USD Million)
Table 50 Neurological Conditions In Canada
Table 51 Canada: Nerve Repair and Regeneration Market, By End User,20152022 (USD Million)
Table 52 Europe: Nerve Repair and Regeneration Market, By Country,20152022 (USD Million)
Table 53 Europe: Nerve Repair and Regeneration Market, By Product,20152022 (USD Million)
Table 54 Europe: Neurostimulation and Neuromodulation Devices Market,By Type, 20152022 (USD Million)
Table 55 Europe: Internal Neurostimulation Devices Market,By Type, 20152022 (USD Million)
Table 56 Europe: External Neurostimulation Devices Market,By Type, 20152022 (USD Million)
Table 57 Europe: Biomaterials Market, By Type, 20152022 (USD Million)
Table 58 Europe: Nerve Repair and Regeneration Market, By Application,20152022 (USD Million)
Table 59 Europe: Nerve Repair and Regeneration Market, By End User,20152022 (USD Million)
Table 60 Asia: Nerve Repair and Regeneration Market, By Country,20152022 (USD Million)
Table 61 Asia: Nerve Repair and Regeneration Market, By Product,20152022 (USD Million)
Table 62 Asia: Neurostimulation and Neuromodulation Devices Market,By Type, 20152022 (USD Million)
Table 63 Asia: Internal Neurostimulation Devices Market, By Type,20152022 (USD Million)
Table 64 Asia: External Neurostimulation Devices Market, By Type,20152022 (USD Million)
Table 65 Asia: Biomaterials Market, By Type, 20152022 (USD Million)
Table 66 Asia: Nerve Repair and Regeneration Market, By Application,20152022 (USD Million)
Table 67 Asia: Nerve Repair and Regeneration Market, By End User,20152022 (USD Million)
Table 68 China: Nerve Repair and Regeneration Market, By End User,20152022 (USD Million)
Table 69 Japan: Nerve Repair and Regeneration Market, By End User,20152022 (USD Million)
Table 70 India: Nerve Repair and Regeneration Market, By End User,20152022 (USD Million)
Table 71 Roa: Nerve Repair and Regeneration Market, By End User,20152022 (USD Million)
Table 72 Row: Nerve Repair and Regeneration Market, By Product,20152022 (USD Million)
Table 73 Row: Neurostimulation and Neuromodulation Devices Market,By Type, 20152022 (USD Million)
Table 74 Row: Internal Neurostimulation Devices Market,By Type, 20152022 (USD Million)
Table 75 Row: External Neurostimulation Devices Market,By Type, 20152022 (USD Million)
Table 76 Row: Biomaterials Market, By Type, 20152022 (USD Million)
Table 77 Row: Nerve Repair and Regeneration Market, By Application,20152022 (USD Million)
Table 78 Row: Nerve Repair and Regeneration Market, By End User,20152022 (USD Million)
Table 79 Growth Strategy Matrix, 20142017
Table 80 Regulatory Approval, 20142017
Table 81 Mergers and Acquisitions, 20142017
Table 82 Product Launches, 20142017
Table 83 Agreements, Collaboration, and Partnerships, 20142017
List of Figures (32 Figures)
Figure 1 Nerve Repair & Regeneration Market Segmentation
Figure 2 Research Design: Nerve Repair & Regeneration Market
Figure 3 Breakdown Of Primary Interviews: By Company Type,Designation, and Region
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Nerve Repair and Regeneration Market Size, By Product,2017 Vs. 2022 (USD Billion)
Figure 8 Nerve Repair and Regeneration Market Size, By Application,2017 Vs. 2022 (USD Billion)
Figure 9 Nerve Repair and Regeneration Market Size, By End User,2017 Vs. 2022 (USD Billion)
Figure 10 Nerve Repair and Regeneration Market Size, By Region,2017 Vs. 2022 (USD Billion)
Figure 11 High Incidence Of Nerve Injuries and Growing Prevalence Of Neurological Disorders To Drive Market Growth
Figure 12 Neurostimulation and Neuromodulation Surgeries To Dominate Market In 2017 (USD Billion)
Figure 13 Asia To Register Highest Cagr During Forecast Period
Figure 14 Xenografts To Continue Registering Highest Growth During Forecast Period (USD Billion)
Figure 15 Nerve Repair and Regeneration Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 Neurostimulation and Neuromodulation Devices Segment Holds Largest Market Share
Figure 17 Neurostimulation and Neuromodulation Surgeries Application Segment To Dominate Market During Forecast Period
Figure 18 Hospitals & Clinics Segment To Dominate Nerve Repair and Regeneration Market During Forecast Period (USD Million)
Figure 19 North America To Dominate Global Nerve Repair and Regeneration Market In 2017 (USD Million)
Figure 20 Asia Nerve Repair and Regeneration Market To Register Highest Cagr During Forecast Period (USD Million)
Figure 21 North America: Nerve Repair and Regeneration Market Snapshot
Figure 22 Asia: Nerve Repair and Regeneration Market Snapshot
Figure 23 Nerve Repair and Regeneration Market Share, By Player (2016)
Figure 24 Axogen: Company Snapshot (2016)
Figure 25 Baxter: Company Snapshot (2016)
Figure 26 Boston Scientific: Company Snapshot (2016)
Figure 27 Livanova: Company Snapshot (2016)
Figure 28 Integra Lifesciences: Company Snapshot (2016)
Figure 29 Medtronic: Company Snapshot (2016)
Figure 30 Abbott Laboratories: Company Snapshot (2016)
Figure 31 Stryker: Company Snapshot (2016)
Figure 32 Nervo: Company Snapshot (2016)
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Nerve Repair and Regeneration Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Nerve Repair and Regeneration Market